What is NewLink Genetics'(nlnk) stock price?
NewLink Genetics trades on the NASDAQ under the ticker symbol "NLNK." What is NewLink Genetics' stock price today? One share of NLNK stock can currently be purchased for approximately $7.00.
How much is a share of nlnk worth?
One share of NLNK stock can currently be purchased for approximately $7.00. How much money does NewLink Genetics make? NewLink Genetics has a market capitalization of $261.30 million and generates $940 thousand in revenue each year.
How much money does NewLink Genetics (NXL) make?
NewLink Genetics has a market capitalization of $261.30 million and generates $940 thousand in revenue each year. The biotechnology company earns $-42.99 million in net income (profit) each year or ($1.03) on an earnings per share basis.
What does NewLink do?
NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve the lives of patients with cancer. The company was founded in 1999 and is based in Ames, Iowa. Most Popular Stories View All View All Top Stories
How were NewLink Genetics' earnings last quarter?
NewLink Genetics Corp (NASDAQ:NLNK) posted its quarterly earnings results on Wednesday, November, 6th. The biotechnology company reported ($0.27) E...
Who are NewLink Genetics' key executives?
NewLink Genetics' management team includes the following people: Dr. Charles J. Link Jr. , Co-Founder, Chairman, CEO & Chief Scientific Officer...
Who are some of NewLink Genetics' key competitors?
Some companies that are related to NewLink Genetics include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron P...
What other stocks do shareholders of NewLink Genetics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other NewLink Genetics investors own include Inovio Pharmaceutic...
What is NewLink Genetics' stock symbol?
NewLink Genetics trades on the NASDAQ under the ticker symbol "NLNK."
What is NewLink Genetics' stock price today?
One share of NLNK stock can currently be purchased for approximately $7.40.
How much money does NewLink Genetics make?
NewLink Genetics (NASDAQ:NLNK) has a market capitalization of $276.23 million and generates $940 thousand in revenue each year. The biotechnology c...
How many employees does NewLink Genetics have?
NewLink Genetics employs 55 workers across the globe.
What is NewLink Genetics' official website?
The official website for NewLink Genetics is www.newlinkgenetics.com .
Component Grades
NLNK Stock Summary
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
NewLink Genetics Corporation (NLNK) Company Bio
NLNK's price/sales ratio is 720.51; that's higher than the P/S ratio of 99.58% of US stocks.
Signals & Forecast
NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve the lives of patients with cancer. The company was founded in 1999 and is based in Ames, Iowa.
Support, Risk & Stop-loss
The NewLink Genetics Corporation stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is NewLink Genetics Corporation stock A Buy?
NewLink Genetics Corporation finds support from accumulated volume at $9.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
About NewLink Genetics Corporation
NewLink Genetics Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Golden Star Signal
NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
NewLink Genetics (NASDAQ:NLNK) Price Target and Consensus Rating
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for NLNK and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
NewLink Genetics (NASDAQ:NLNK) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
How much is the EV charging station market worth?
MarketBeat users like NewLink Genetics stock more than the stock of other Medical companies. 71.56% of MarketBeat users gave NewLink Genetics an outperform vote while medical companies recieve an average of 67.57% outperform votes by MarketBeat users.
What is retail industry?
As the adoption of electric vehicles (EV) is rising, the demand for EV charging stations is also rising. According to a Fortune Business Insights report, the global EV charging station market was worth $39.70 billion in 2019 and is expected to reach $100.96 billion by 2027, indicating a compounded annual growth rate (CAGR) of 23.24% . Using the TipRanks Stock Comparison tool, let us compare two EV charging station companies, Blink Charging Co. and ChargePoint Holdings, and see how Wall Street an
Who is the CEO of Blink Charging?
The retail industry provides a variety of finished goods, both durable and non-durable, to individual consumers and households. The industry also sells services. Products sold by retail companies include apparel, electronics, furniture, kitchenware, sporting goods, books, and toys.